Abstract
TC21 is a Ras-like GTPase with high oncogenic potential that is found mutated in some human tumors and overexpressed in breast cancer cell lines. We have conducted cellular and biochemical studies in order to understand the role of this protein in signal transduction and to unveil the signaling elements that participate in the TC21 pathway. Using gene transfer experiments, we demonstrate here that the TC21 oncogene can induce both cellular transformation in mouse fibroblasts and neuronal-like differentiation in rat PC12 cells. Interestingly, the proto-oncogenic version of TC21 shows also a lower, but significant, activity in both biological processes. We also demonstrate that the similarity of the cellular responses induced by TC21 and Ras derive from the utilization of overlapping pathways. Thus, the exchange of guanosine nucleotides in wild type TC21 is catalyzed by Ras exchange factors. Moreover, TC21 binds physically to c-Raf-1 in a GTP-dependent manner. Finally, overexpression of TC21G23V in NIH3T3 cells results in the activation of c-Raf-1 and the MAPK and the JNK branches of serine/threonine cascades. From these results, we conclude that TC21 promotes Ras-like responses in diverse cell types due to the use of overlapping, if not identical, signaling elements of the Ras oncogenic pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bar-Sagi D and Feramisco JR. . 1985 Cell 42: 841–848.
Boguski MS and McCormick F. . 1993 Nature 366: 643–654.
Boriack-Sjodin PA, Margarit SM, Bar-Sagi D and Kuriyan J. . 1998 Nature 394: 337–343.
Bustelo XR. . 1996 Crit. Rev. Oncog. 7: 65–88.
Bustelo XR, Suen KL, Leftheris K, Meyers CA and Barbacid M. . 1994 Oncogene 9: 2405–2413.
Carboni JM, Yan N, Cox AD, Bustelo X, Graham SM, Lynch MJ, Weinmann R, Seizinger BR, Der CJ, Barbacid M and Manne V. . 1995 Oncogene 10: 1905–1913.
Cerione RA and Zheng Y. . 1996 Curr. Opin. Cell. Biol. 8: 216–222.
Chan AM, Miki T, Meyers KA and Aaronson SA. . 1994 Proc. Natl. Acad. Sci. USA 91: 7558–7562.
Clark GJ, Kinch MS, Gilmer TM, Burridge K and Der CJ. . 1996 Oncogene 12: 169–176.
Coppola J, Bryant S, Koda T, Conway D and Barbacid M. . 1991 Cell Growth Differ. 2: 95–105.
Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T and Gutkind JS. . 1995 Cell 81: 1137–1146.
Cox AD, Brtva TR, Lowe DG and Der CJ. . 1994 Oncogene 9: 3281–3288.
Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M, Barbacid M and Gutkind JS. . 1996 Oncogene 13: 455–460.
Crespo P, Schuebel KE, Ostrom AA, Gutkind JS and Bustelo XR. . 1997 Nature 385: 169–172.
Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR and Aaronson SA. . 1993 Oncogene 8: 2443–2448.
Drivas GT, Shih A, Coutavas E, Rush MG and D'Eustachio P. . 1990 Mol. Cell. Biol. 10: 1793–1798.
Gotoh T, Niino Y, Tokuda M, Hatase O, Nakamura S, Matsuda M and Hattori S. . 1997 J. Biol. Chem. 272: 18602–18607.
Graham SM, Cox AD, Drivas G, Rush MG, D'Eustachio P and Der CJ. . 1994 Mol. Cell. Biol. 14: 4108–4115.
Graham SM, Vojtek AB, Huff SY, Cox AD, Clark GJ, Cooper JA and Der CJ. . 1996 Mol. Cell. Biol. 16: 6132–6140.
Huang Y, Saez R, Chao L, Santos E, Aaronson SA and Chan AM. . 1995 Oncogene 11: 1255–1260.
Kozian DH and Augustin HG. . 1997 FEBS Lett. 414: 239–242.
Laudanna C, Campbell JJ and Butcher EC. . 1996 Science 271: 981–983.
Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF and Sargiacomo M. . 1994 J. Cell Biol. 126: 111–126.
Lopez-Barahona M, Bustelo XR and Barbacid M. . 1996 Oncogene 12: 463–470.
Marshall CJ. . 1996 Curr. Opin. Cell. Biol. 8: 197–204.
Marte BM, Rodriguez-Viciana P, Wennstrom S, Warne PH and Downward J. . 1997 Curr. Biol. 7: 63–70.
Minden A, Lin A, Claret FX, Abo A and Karin M. . 1995 Cell 81: 1147–1157.
Morrison DK. . 1995 Meth. Enzymol. 255: 301–310.
Rosário M, Paterson HF and Marshall J. . 1999 EMBO J. 18: 1270–1279.
Santos E, Tronick SR, Aaronson SA, Pulciani S and Barbacid M. . 1982 Nature 298: 343–347.
Schuebel KE, Movilla N, Rosa JL and Bustelo XR. . 1998 EMBO J. 17: 6608–6621.
Shou C, Farnsworth CL, Neel BG and Feig LA. . 1992 Nature 358: 351–354.
Sigal IS, Gibbs JB, D'Alonzo JS, Temeles GL, Wolanski BS, Socher SH and Scolnick EM. . 1986 Proc. Natl. Acad. Sci. USA 83: 952–956.
Suen KL, Bustelo XR and Barbacid M. . 1995 Oncogene 11: 825–831.
van der Eb AJ and Graham FL. . 1980 Meth. Enzymol. 65: 826–839.
Acknowledgements
We would like to thank Dr Barbacid for the generous supply of many of the TC21 and Ras reagents used in this study. This work was supported by grants from both the National Cancer Institute (CA7373501) and the Carol M Baldwin Foundation for Breast Cancer Research to XR Bustelo and from the Fundación Botín to P Crespo. XR Bustelo is a Sinsheimer Scholar for Cancer Research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Movilla, N., Crespo, P. & Bustelo, X. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Oncogene 18, 5860–5869 (1999). https://doi.org/10.1038/sj.onc.1202968
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202968
Keywords
This article is cited by
-
Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors
Oncogene (2023)
-
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia
Molecular Cancer (2022)
-
R-Ras subfamily proteins elicit distinct physiologic effects and phosphoproteome alterations in neurofibromin-null MPNST cells
Cell Communication and Signaling (2021)
-
Contribution of the R-Ras2 GTP-binding protein to primary breast tumorigenesis and late-stage metastatic disease
Nature Communications (2014)
-
Integrated genomics and proteomics of the Torpedo californica electric organ: concordance with the mammalian neuromuscular junction
Skeletal Muscle (2011)